あすか製薬ホールディングスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/05/25 | 989 | 992 | 979 | 979 | -1 | -0.1% | 64,000 |
| 2022/05/24 | 998 | 1,003 | 978 | 980 | -18 | -1.8% | 99,600 |
| 2022/05/23 | 1,003 | 1,010 | 989 | 998 | ±0 | ±0% | 56,400 |
| 2022/05/20 | 985 | 1,002 | 980 | 998 | +16 | +1.6% | 60,600 |
| 2022/05/19 | 972 | 985 | 958 | 982 | -13 | -1.3% | 98,200 |
| 2022/05/18 | 1,000 | 1,003 | 984 | 995 | -1 | -0.1% | 108,900 |
| 2022/05/17 | 1,002 | 1,009 | 987 | 996 | +9 | +0.9% | 69,100 |
| 2022/05/16 | 1,009 | 1,015 | 985 | 987 | -13 | -1.3% | 162,500 |
| 2022/05/13 | 1,013 | 1,028 | 986 | 1,000 | -73 | -6.8% | 185,300 |
| 2022/05/12 | 1,140 | 1,144 | 1,070 | 1,073 | -81 | -7% | 98,200 |
| 2022/05/11 | 1,146 | 1,184 | 1,124 | 1,154 | +1 | +0.1% | 54,400 |
| 2022/05/10 | 1,160 | 1,166 | 1,145 | 1,153 | -26 | -2.2% | 52,700 |
| 2022/05/09 | 1,203 | 1,207 | 1,179 | 1,179 | -21 | -1.8% | 61,900 |
| 2022/05/06 | 1,205 | 1,210 | 1,185 | 1,200 | +8 | +0.7% | 68,700 |
| 2022/05/02 | 1,189 | 1,205 | 1,180 | 1,192 | +3 | +0.3% | 73,600 |
| 2022/04/28 | 1,148 | 1,190 | 1,134 | 1,189 | +65 | +5.8% | 85,300 |
| 2022/04/27 | 1,159 | 1,159 | 1,115 | 1,124 | -54 | -4.6% | 204,400 |
| 2022/04/26 | 1,141 | 1,186 | 1,130 | 1,178 | +37 | +3.2% | 87,000 |
| 2022/04/25 | 1,128 | 1,152 | 1,127 | 1,141 | -17 | -1.5% | 56,100 |
| 2022/04/22 | 1,160 | 1,168 | 1,144 | 1,158 | -10 | -0.9% | 66,900 |
| 2022/04/21 | 1,169 | 1,178 | 1,162 | 1,168 | -1 | -0.1% | 48,500 |
| 2022/04/20 | 1,187 | 1,188 | 1,162 | 1,169 | +1 | +0.1% | 64,600 |
| 2022/04/19 | 1,194 | 1,200 | 1,168 | 1,168 | -2 | -0.2% | 57,300 |
| 2022/04/18 | 1,212 | 1,212 | 1,168 | 1,170 | -59 | -4.8% | 84,700 |
| 2022/04/15 | 1,264 | 1,264 | 1,225 | 1,229 | -44 | -3.5% | 62,900 |
| 2022/04/14 | 1,250 | 1,273 | 1,250 | 1,273 | +7 | +0.6% | 64,800 |
| 2022/04/13 | 1,250 | 1,266 | 1,243 | 1,266 | +9 | +0.7% | 81,100 |
| 2022/04/12 | 1,284 | 1,285 | 1,250 | 1,257 | -34 | -2.6% | 105,000 |
| 2022/04/11 | 1,309 | 1,310 | 1,280 | 1,291 | -22 | -1.7% | 92,700 |
| 2022/04/08 | 1,347 | 1,347 | 1,292 | 1,313 | -47 | -3.5% | 170,400 |
| 2022/04/07 | 1,328 | 1,362 | 1,315 | 1,360 | +26 | +1.9% | 129,500 |
| 2022/04/06 | 1,303 | 1,336 | 1,303 | 1,334 | +16 | +1.2% | 96,100 |
| 2022/04/05 | 1,333 | 1,345 | 1,312 | 1,318 | ±0 | ±0% | 112,600 |
| 2022/04/04 | 1,295 | 1,325 | 1,294 | 1,318 | +48 | +3.8% | 165,500 |
| 2022/04/01 | 1,250 | 1,279 | 1,234 | 1,270 | +7 | +0.6% | 117,200 |
| 2022/03/31 | 1,250 | 1,290 | 1,247 | 1,263 | +3 | +0.2% | 134,300 |
| 2022/03/30 | 1,267 | 1,300 | 1,252 | 1,260 | -3 | -0.2% | 181,500 |
| 2022/03/29 | 1,243 | 1,265 | 1,218 | 1,263 | +127 | +11.2% | 407,700 |
| 2022/03/28 | 1,157 | 1,157 | 1,131 | 1,136 | -21 | -1.8% | 30,900 |
| 2022/03/25 | 1,170 | 1,175 | 1,154 | 1,157 | -13 | -1.1% | 40,800 |
| 2022/03/24 | 1,153 | 1,171 | 1,137 | 1,170 | +5 | +0.4% | 64,000 |
| 2022/03/23 | 1,136 | 1,169 | 1,132 | 1,165 | +44 | +3.9% | 127,400 |
| 2022/03/22 | 1,164 | 1,164 | 1,112 | 1,121 | -27 | -2.4% | 111,700 |
| 2022/03/18 | 1,151 | 1,163 | 1,141 | 1,148 | -1 | -0.1% | 150,000 |
| 2022/03/17 | 1,145 | 1,154 | 1,137 | 1,149 | +22 | +2% | 114,000 |
| 2022/03/16 | 1,144 | 1,144 | 1,121 | 1,127 | +3 | +0.3% | 139,000 |
| 2022/03/15 | 1,110 | 1,135 | 1,100 | 1,124 | +7 | +0.6% | 79,700 |
| 2022/03/14 | 1,110 | 1,128 | 1,094 | 1,117 | +15 | +1.4% | 88,900 |
| 2022/03/11 | 1,108 | 1,112 | 1,086 | 1,102 | -18 | -1.6% | 82,500 |
| 2022/03/10 | 1,093 | 1,120 | 1,084 | 1,120 | +58 | +5.5% | 115,200 |
751～
800
件表示中 / 1029件
類似銘柄と比較する
現在ご覧いただいている「あすかＨＤ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| あすかＨＤ | 233,000円 | +16.9% | +33.2% | 2.36% | 12.71倍 | 1.01倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
| ネクセラファーマ | 92,000円 | +20.3% | - | 0.00% | 163.12倍 | 1.22倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| ＪＣＲファーマ | 55,400円 | +14.3% | - | 3.61% | 22.50倍 | 1.44倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| タウンズ | 56,800円 | +4.6% | +6.1% | 4.93% | 9.68倍 | 3.58倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
| ヘリオス | 54,100円 | +150.0% | - | 0.00% | - | 26.61倍 |
|
ｉＰＳ細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
市場注目の銘柄
チャート関連のコラム
